IP - Desktop Hero

Patents

We advise companies on how best to capitalise on, defend and co-operate based on their patent-protected innovations.

Please select

Out-Law / Your daily need to know

Our latest work

Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.

  • Teva Pharmaceutical

    Acted for Teva who initiated a claim for revocation of Gilead's Supplementary Protection Certificate ('SPC') for Truvada®, a dual combination product containing tenofovir disoproxil and emtricitibine, for the treatment of HIV. Following trial in December 2016, Mr Justice Arnold referred a question to the Court of Justice of the European Union in relation to what the criteria are for deciding whether the product is protected by a basic patent in force under Article 3(a) of the SPC Regulation.

    Read more
  • Teva Pharmaceutical Industries Limited

    Advised and litigated on behalf of Teva Pharmaceutical Industries, a leading global pharmaceutical company, on regulatory and patent matters concerning the launch of dimethyl fumarate in the Netherlands.

  • Sandoz Limited

    Advising Sandoz AG on interim injunction proceedings, and patent revocation and infringement proceedings following the launch in the UK of its generic dapagliflozin product.

  • Sandoz AG

    Advised Sandoz AG, a global generics and biosimilars manufacturer, on revocation proceedings before the UK Patents Court concerning a dosing regime patent for Rivaroxaban (Xarelto), and on the subsequent damages enquiry arising from a wrongly granted interim injunction.

  • Park Grove IP Limited

    Advised Dana Fabre, a pharmaceutical company, on its appeal against a UK IPO decision refusing a paediatric extension to its SPCs protecting Tecentriq and Bavencio.

  • Heumann Pharma GmbH & Co. Generica KG

    Advised Torrent, a leading pharmaceutical company, on patent litigation against Sanofi related to teriflunomide.

  • Accord Healthcare Limited

    Representing Accord in revocation proceedings before the UK Patents Court concerning a patent protecting a subcutaneous formulation of Herceptin (trastuzumab) the blockbuster breast cancer drug.

  • Client confidential

    Advising global pharmaceutical companies on regulatory matters, including marketing authorisation filing for fixed-dose combination products, interpretation of the Centralised Procedure framework, and strategic carve outs of indications or safety features from applications due to patent rights.

  • Safran Seats GB Limited

    Acting for Safran Seats in patent litigation arising out of a patent infringement action commenced by Lufthansa Technik AG against Astronics AES, Panasonic Avionics Corp and Safran. The patent in issue concerns a safety device used in electrical systems in commercial aircraft.

  • Client confidential

    Assisting a biotechnology company with patent litigation relating to patent entitlement issues in the field of functional plant-based proteins

Our expertise, at your disposal

With over 490 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.

Latest press releases

Show me all press releases

Pinsent Masons achieves highest number of Legal 500 UK rankings

Multinational law firm Pinsent Masons has once again topped the Legal 500 UK rankings, securing both the highest number of overall rankings and the most Tier One rankings.

Pinsent Masons advises EDF power solutions on Five Estuaries Offshore Wind Farm acquisition

Multinational law firm Pinsent Masons has advised long-standing client EDF power solutions on its acquisition of a 33.3% interest in the Five Estuaries Offshore Wind Farm project from RWE, marking a significant addition to EDF power solutions’ UK offshore wind development portfolio.

Pinsent Masons bolsters Dublin office with new corporate tax partner James Quirke

Multinational law firm Pinsent Masons has appointed new partner James Quirke to lead its corporate tax team in Dublin.

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.